Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.31 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26813596 | 0.91 | CYP3A4 (0.33) | DHODHALOX5APKDM4EMAPK14LCK | |
| SCHEMBL26060531 | 0.84 | AAK1 (0.34) | MAPK14 | |
| SCHEMBL25518863 | 0.83 | KDM4E (0.31) | KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL26060418 | 0.82 | MAPK14 (0.31) | MAPK14PTGESLCKKDRJAK3 | |
| SCHEMBL25716794 | 0.81 | AAK1 (0.30) | — | |
| SCHEMBL26060419 | 0.81 | LMNA (0.39) | MAPK14PTGESLCKKDRJAK3 | |
| SCHEMBL26813690 | 0.80 | HTR1A (0.38) | MAPK14PTGESLCKKDRJAK3 | |
| SCHEMBL26060446 | 0.80 | PDE2A (0.33) | MAPK14 | |
| SCHEMBL26060421 | 0.79 | GRM2 (0.33) | MAPK14 | |
| SCHEMBL25443013 | 0.79 | HTR2A (0.33) | DHODHGABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11832456-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230287263-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-14 | — | — | US | disclosed |
| US-11692132-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11832456-B2 | Organic electroluminescent materials and devices | CPNE4, CYBA, EPCAM | DHODH 2570/4885ALOX5AP 1680/4885KDM4E 807/4885 |
| US-11692132-B2 | Organic electroluminescent materials and devices | OSBP, OCIAD1, OCIAD2 | DHODH 1164/4885ALOX5AP 2029/4885KDM4E 4627/4885 |
| US-20230287263-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OCIAD1, OCIAD2 | DHODH 1164/4885ALOX5AP 2029/4885KDM4E 4627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.